VIR

SVF Endurance (Cayman) Ltd

Known title: 10% OwnerCIK: 0001782338

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Vir Biotechnology Secures $1.875B Gilead Deal for Cancer Drug Candidates. Vir Biotechnology entered a $1.875 billion partnership with Gilead that includes an upfront cash payment and shares, plus up to $1.785 billion in milestone payments and royalties. The collaboration also covers three PRO‑XTEN dual‑masked T‑cell engager candidates for solid tumors, with one, VIR‑5500, receiving FDA Fast‑Track status for metastatic castration‑resistant prostate cancer. These developments expand Vir’s oncology pipeline and strengthen its relationship with a major biopharma partner.

this person other insiders at VIR

Transaction History

VIR▼ Sell$1.1M
VIR▼ Sell$396K
VIR▼ Sell$818K
VIR▼ Sell$1.5M
VIR▼ Sell$1.4M
VIR▼ Sell$649
VIR▼ Sell$159K
VIR▼ Sell$402K
VIR▼ Sell$278K
VIR▼ Sell$925K
VIR▼ Sell$888K
VIR▼ Sell$691K
VIR▼ Sell$1.4M
VIR▼ Sell$78K
VIR▼ Sell$101K
VIR▼ Sell$14K
VIR▼ Sell$1.5M
VIR▼ Sell$2.8M
VIR▼ Sell$404K
VIR▼ Sell$421K
VIR▼ Sell$2.5M
VIR▼ Sell$18K
VIR▼ Sell$2.3M
VIR▼ Sell$176K
VIR▼ Sell$249K
VIR▼ Sell$2.8M
VIR▼ Sell$445K
VIR▼ Sell$1.4M
VIR▼ Sell$63K
VIR▼ Sell$543K
VIR▼ Sell$952K
VIR▼ Sell$1.9M
VIR▼ Sell$980K
VIR▼ Sell$142K
VIR▼ Sell$939K
VIR▼ Sell$914K
VIR▼ Sell$63K
VIR▼ Sell$1.8M
VIR▼ Sell$60K
VIR▼ Sell$3.8M
VIR▼ Sell$631K
VIR▼ Sell$2.4M
VIR▼ Sell$2.3M
VIR▼ Sell$3K
VIR▼ Sell$2.9M
VIR▼ Sell$2.1M
VIR▼ Sell$78K
VIR▼ Sell$24K
VIR▼ Sell$1.7M
VIR▼ Sell$7.5M
VIR▼ Sell$414K
VIR▼ Sell$165K
VIR▼ Sell$1.9M
VIR▼ Sell$175K
VIR▼ Sell$264K
VIR▼ Sell$240K
VIR▼ Sell$7K
VIR▼ Sell$202K
VIR▼ Sell$1.8M
VIR▼ Sell$85K
VIR▼ Sell$1.0M
VIR▼ Sell$1.0M
VIR▼ Sell$691K
VIR▼ Sell$1.4M
VIR▼ Sell$332K
VIR▼ Sell$2.2M
VIR▼ Sell$14K
VIR▼ Sell$258K
VIR▼ Sell$3.3M
VIR▼ Sell$38K
VIR▼ Sell$987K
VIR▼ Sell$1.3M
VIR▼ Sell$128K
VIR▼ Sell$1.7M
VIR▼ Sell$910K
VIR▼ Sell$444K
VIR▼ Sell$189K
VIR▼ Sell$1.9M
VIR▼ Sell$2.6M
VIR▼ Sell$767K
VIR▼ Sell$1.0M
VIR▼ Sell$96K
VIR▼ Sell$2.1M
VIR▼ Sell$2.0M
VIR▼ Sell$360K
VIR▼ Sell$178K
VIR▼ Sell$857K
VIR▼ Sell$580K
VIR▼ Sell$3.4M
VIR▼ Sell$1.7M
VIR▼ Sell$105K
VIR▼ Sell$2.7M
VIR▼ Sell$2.3M
VIR▼ Sell$2.5M
VIR▼ Sell$306K
VIR▼ Sell$2.8M
VIR▼ Sell$23K
VIR▼ Sell$2.1M
VIR▼ Sell$1.9M
VIR▼ Sell$770K
VIR▼ Sell$130K
VIR▼ Sell$1.5M
VIR▼ Sell$242K
VIR▼ Sell$25K
VIR▼ Sell$209K
VIR▼ Sell$1.1M
VIR▼ Sell$175K
VIR▼ Sell$2.1M
VIR▼ Sell$8K
VIR▼ Sell$1.9M
VIR▼ Sell$590K
VIR▼ Sell$410K
VIR▼ Sell$2.5M
VIR▼ Sell$2.7M
VIR▼ Sell$241K
VIR▼ Sell$2.4M
VIR▼ Sell$1.1M
VIR▼ Sell$171K
VIR▼ Sell$2.8M
VIR▼ Sell$1.8M
VIR▼ Sell$1.9M
VIR▼ Sell$25K
VIR▼ Sell$1.0M
VIR▼ Sell$470K
VIR▼ Sell$1.1M
VIR▼ Sell$1.8M
VIR▼ Sell$20K
VIR▼ Sell$687K
VIR▼ Sell$2.0M
VIR▼ Sell$30K
VIR▼ Sell$3.7M
VIR▼ Sell$341K
VIR▼ Sell$2.1M
VIR▼ Sell$1.4M
VIR▼ Sell$4.3M
VIR▼ Sell$3.4M
VIR▼ Sell$143K
VIR▼ Sell$1.3M
VIR▼ Sell$3.6M
VIR▼ Sell$216K
VIR▼ Sell$1.7M
VIR▼ Sell$1.7M
VIR▼ Sell$21.1M

We use analytics to understand how market-wall is used. No personal data is sold.